Article citationsMore>>
Mross K., F.R., Richly, H., Scharr, D., Buechert, M., Stern, A., Hoth, D., Gille, H., Audoly, L.P. and Scheulen M.E. (2011) First in human phase I study of PRS-050 (Angiocal), a VEGF-A targeting anticalin, in patients with advanced solid tumors: Results of a dose escalation study. American Association for Cancer Research, 10, A212. doi:10.1158/1535-7163.TARG-11-A212
has been cited by the following article:
Related Articles:
-
Daniel Oruzio, Günter Waxenecker, Christoph Aulmann, Bruno Märkl, Theodor Wagner, Geert Mudde, Manfred Schuster, Norbert Eller, Andrea Mayer, Stefan Stranner, Gottfried Himmler, Hans Loibner, Günter Schlimok, Ralf Kircheis, Andreas Nechansky
-
Guillermo López Vivanco, Eider Azkona, Sergio Carrera, Aintzane Sancho, Itziar Rubio, Juan Manuel Mañé, Begoña Calvo, Unai Aresti, Aitziber Buque, Inés Marrodán, Alberto Muñoz
-
Abdelkarim S. Allal, Arnaud D. Roth, Alessandra Franzetti-Pellanda, Marta Bonet, Pascal Gervaz, Sabine Bieri
-
Karen-Lise Garm Spindler, Niels Pallisgaard, Rikke Fredslund Andersen, John Ploen, Anders Jakobsen
-
Kanyarat Katanyoo, Kanisa Rongsriyam, Marisa Chongtanakon